Gossamer Bio, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
7.42
|
|
Average Rating
|
4.15
|
|
# Strong Buys
|
6
|
|
# Buys
|
4
|
|
# Holds
|
2
|
|
# Sells
|
1
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.63
|
-0.65
|
-0.02
|
-3.17%
|
|
2022-06-30
|
-0.70
|
-0.74
|
-0.04
|
-5.71%
|
|
2022-03-31
|
-0.77
|
-0.76
|
0.01
|
1.30%
|
|
2021-12-31
|
-0.74
|
-0.74
|
0.00
|
0.00%
|
|
2021-09-30
|
-0.78
|
-0.80
|
-0.02
|
-2.56%
|
|
2021-06-30
|
-0.76
|
-0.80
|
-0.04
|
-5.26%
|
|
2021-03-31
|
-0.75
|
-0.78
|
-0.03
|
-4.00%
|
|
2020-12-31
|
-0.79
|
-0.88
|
-0.09
|
-11.39%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-2.15
|
|
2021-12-31
|
-3.12
|
|
2020-12-31
|
-3.55
|
|
2019-12-31
|
-3.33
|
|
2018-12-31
|
-19.16
|